Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.06
OMCM's Cash to Debt is ranked lower than
96% of the 1714 Companies
in the Global Health Information Services industry.

( Industry Median: 17.11 vs. OMCM: 0.06 )
Ranked among companies with meaningful Cash to Debt only.
OMCM' s 10-Year Cash to Debt Range
Min: 0  Med: 0.04 Max: N/A
Current: 0.06
Equity to Asset -6.31
OMCM's Equity to Asset is ranked lower than
100% of the 1511 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. OMCM: -6.31 )
Ranked among companies with meaningful Equity to Asset only.
OMCM' s 10-Year Equity to Asset Range
Min: -17.38  Med: -6.11 Max: -0.05
Current: -6.31
-17.38
-0.05
F-Score: 3
Z-Score: -20.26
M-Score: -5.09
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -5.65
OMCM's Operating margin (%) is ranked lower than
75% of the 1686 Companies
in the Global Health Information Services industry.

( Industry Median: 5.08 vs. OMCM: -5.65 )
Ranked among companies with meaningful Operating margin (%) only.
OMCM' s 10-Year Operating margin (%) Range
Min: -8416.9  Med: -124.95 Max: 3.86
Current: -5.65
-8416.9
3.86
Net-margin (%) -31.49
OMCM's Net-margin (%) is ranked lower than
85% of the 1686 Companies
in the Global Health Information Services industry.

( Industry Median: 3.22 vs. OMCM: -31.49 )
Ranked among companies with meaningful Net-margin (%) only.
OMCM' s 10-Year Net-margin (%) Range
Min: -8545.07  Med: -147.29 Max: -22.06
Current: -31.49
-8545.07
-22.06
ROA (%) -95.73
OMCM's ROA (%) is ranked lower than
94% of the 1724 Companies
in the Global Health Information Services industry.

( Industry Median: 3.09 vs. OMCM: -95.73 )
Ranked among companies with meaningful ROA (%) only.
OMCM' s 10-Year ROA (%) Range
Min: -978.32  Med: -353.51 Max: -84.23
Current: -95.73
-978.32
-84.23
ROC (Joel Greenblatt) (%) -599.89
OMCM's ROC (Joel Greenblatt) (%) is ranked lower than
91% of the 1699 Companies
in the Global Health Information Services industry.

( Industry Median: 22.78 vs. OMCM: -599.89 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OMCM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4027.27  Med: -846.27 Max: -105.97
Current: -599.89
-4027.27
-105.97
Revenue Growth (3Y)(%) 4.00
OMCM's Revenue Growth (3Y)(%) is ranked lower than
54% of the 1285 Companies
in the Global Health Information Services industry.

( Industry Median: 5.00 vs. OMCM: 4.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OMCM' s 10-Year Revenue Growth (3Y)(%) Range
Min: -58.1  Med: 11.90 Max: 81.7
Current: 4
-58.1
81.7
EPS Growth (3Y)(%) 7.70
OMCM's EPS Growth (3Y)(%) is ranked higher than
52% of the 938 Companies
in the Global Health Information Services industry.

( Industry Median: 6.50 vs. OMCM: 7.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OMCM' s 10-Year EPS Growth (3Y)(%) Range
Min: -47.7  Med: -12.60 Max: 18.6
Current: 7.7
-47.7
18.6
» OMCM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with OMCM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 1.01
OMCM's P/S is ranked higher than
74% of the 1858 Companies
in the Global Health Information Services industry.

( Industry Median: 2.46 vs. OMCM: 1.01 )
Ranked among companies with meaningful P/S only.
OMCM' s 10-Year P/S Range
Min: 0.19  Med: 1.73 Max: 10.14
Current: 1.01
0.19
10.14
Current Ratio 0.22
OMCM's Current Ratio is ranked lower than
98% of the 1553 Companies
in the Global Health Information Services industry.

( Industry Median: 2.07 vs. OMCM: 0.22 )
Ranked among companies with meaningful Current Ratio only.
OMCM' s 10-Year Current Ratio Range
Min: 0.02  Med: 0.15 Max: 0.98
Current: 0.22
0.02
0.98
Quick Ratio 0.22
OMCM's Quick Ratio is ranked lower than
98% of the 1553 Companies
in the Global Health Information Services industry.

( Industry Median: 1.93 vs. OMCM: 0.22 )
Ranked among companies with meaningful Quick Ratio only.
OMCM' s 10-Year Quick Ratio Range
Min: 0.02  Med: 0.15 Max: 0.98
Current: 0.22
0.02
0.98
Days Sales Outstanding 57.80
OMCM's Days Sales Outstanding is ranked higher than
62% of the 1453 Companies
in the Global Health Information Services industry.

( Industry Median: 68.81 vs. OMCM: 57.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMCM' s 10-Year Days Sales Outstanding Range
Min: 2.32  Med: 47.02 Max: 229.17
Current: 57.8
2.32
229.17

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.57
OMCM's Price/Median PS Value is ranked higher than
91% of the 1577 Companies
in the Global Health Information Services industry.

( Industry Median: 1.22 vs. OMCM: 0.57 )
Ranked among companies with meaningful Price/Median PS Value only.
OMCM' s 10-Year Price/Median PS Value Range
Min: 0.16  Med: 2.00 Max: 100
Current: 0.57
0.16
100
Earnings Yield (Greenblatt) (%) -8.30
OMCM's Earnings Yield (Greenblatt) (%) is ranked lower than
84% of the 1741 Companies
in the Global Health Information Services industry.

( Industry Median: 2.50 vs. OMCM: -8.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OMCM' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -8.3  Med: 2.35 Max: 5.6
Current: -8.3
-8.3
5.6

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Omnicomm Systems Inc was incorporated on February 17, 1999. The Company provides web-based electronic data capture and eClinical software and services for the clinical research process. Its eClinical software and service offerings include TrialMaster, TrialOne and eClinical Suite, Promasys. Its eClinical Products are designed to allow clinical trial sponsors and investigative sites to easily and securely collect, validate, transmit, and analyze clinical study data. The eClinical Products are 21 CFR Part 11 compliant solutions and are designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms, with significant flexibility, ease-of-use and with complete control over collected data. The Company also provides business process consulting services that focus on more effectively integrating EDC and eClinical Solutions and processes into the clinical trial process.Its customers include pharmaceutical, biotechnology, medical device companies, academic institutions, clinical research organizations and other entities engaged in clinical trials. The Company competes with systems and paper-based processes utilized by existing or prospective customers, as well as other commercial vendors of EDC and eClinical applications, clinical data management systems and adverse event reporting software The conduct of clinical trials is subject to regulation and regulatory guidance associated with the approval of new drugs, biological products and medical devices imposed upon the clinical trial process by the U.S. federal government and related regulatory authorities such as the U.S. Food and Drug Administration, or FDA, and by foreign governments.
» More Articles for OMCM

Headlines

Articles On GuruFocus.com
OmniComm Systems(R) Announces 141% YOY Growth in Total Contract Value Jan 16 2015 
OmniComm Systems(R) Recognizes Excellence in Clinical Research and Development at Innovation Forum 2 Dec 19 2014 
OmniComm Systems(R) Announces 135% YOY Growth in Total Contract Value Through Q3 2014 Nov 26 2014 
Larix, Denmark's Full Service Contract Research Organization, Selects OmniComm's(R) TrialMaster(R) E Nov 20 2014 
Belgian Contract Research Organization, Business & Decision Life Sciences, Partners With OmniComm Sy Oct 28 2014 
Top 10 Pharmaceutical Company Moves to OmniComm Systems'(R) OmniCloud(R) Oct 20 2014 

More From Other Websites
OmniComm Systems Common Stock Upgrades to Trade on OTCQX Best Marketplace Jul 01 2015
OTC Markets Group Welcomes OmniComm Systems, Inc. to OTCQX Jul 01 2015
OmniComm Systems(R) Expands Presence in Japan and Philippines Jun 15 2015
OMNICOMM SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 12 2015
Leading Global Biopharmaceutical Selects TrialMaster(R) EDC for CNS Drug Trials Jun 09 2015
OMNICOMM SYSTEMS INC Financials May 27 2015
10-Q for OmniComm Systems, Inc. May 18 2015
OMNICOMM SYSTEMS INC Files SEC form 10-Q, Quarterly Report May 15 2015
10-K for OmniComm Systems, Inc. Apr 26 2015
OmniComm Systems Announces Innovative New Release of TrialMaster(R) EDC Apr 01 2015
OMNICOMM SYSTEMS INC Files SEC form 10-K, Annual Report Mar 31 2015
Veloxis Pharmaceuticals Chooses TrialMaster(R) EDC for Risk-Based Monitoring Mar 11 2015
OmniComm Systems(R) TrialOne(R) Suite Selected by ICON for Phase I Clinic Automation Mar 03 2015
European Group for Research in Schizophrenia Selects OmniComm Systems(R) TrialMaster(R) Risk-Based &... Feb 24 2015
OmniComm Systems Appoints General Manager of China; Mr. Feng Cheng Focuses on Expanding Growth and... Feb 09 2015
OmniComm Systems(R) Acquires IRT Technology From ClinQuest Feb 06 2015
OmniComm Systems(R) Announces 141% YOY Growth in Total Contract Value Jan 16 2015
OmniComm Systems(R) Recognizes Excellence in Clinical Research and Development at Innovation Forum... Dec 19 2014
Merge Healthcare (MRGE) Worth Watching: Stock Gains 6.5% Dec 04 2014
OMNICOMM SYSTEMS INC Files SEC form 8-K, Other Events Nov 26 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK